BACKGROUND: The 5α-reduced pregnane neuroactive steroid (3α,5α)-3-hydroxypregnan-20-one (3α,5α-THP or allopregnanolone) is a potent positive modulator of GABAA receptors capable of modulating neuronal activity. In rats, systemic ethanol (EtOH) administration increases cerebral cortical and hippocampal levels of 3α,5α-THP, but the effects of EtOH on 3α,5α-THP levels in other brain regions are unknown. There is a large body of evidence suggesting that 3α,5α-THP enhances EtOH sensitivity, contributes to some behavioral effects of EtOH, and modulates EtOH reinforcement and motivation to drink. In this study, we used immunohistochemistry (IHC) to determine EtOH-induced changes in cellular 3α,5α-THP expression in brain regions associated with EtOH actions and responses. METHODS: Male Wistar rats were administered EtOH (2 g/kg) or saline intraperitoneally and after 60 minutes transcardially perfused. IHC was performed on free-floating sections (3 to 4 sections/animal/brain region) using an affinity purified anti-3α,5α-THP primary antibody, and immunoreactivity was visualized with 3,3'-diaminobenzidine. RESULTS: EtOH significantly increased 3α,5α-THP immunoreactivity by 24 ± 6% in the medial prefrontal cortex, 32 ± 12% in the hippocampal Cornu Ammonis area 1 (CA1) pyramidal cell layer, 52 ± 5% in the polymorph cell layer of the dentate gyrus (DG), 44 ± 15% in the bed nucleus of the stria terminalis, and 36 ± 6% in the paraventricular nucleus of the hypothalamus. In contrast, EtOH administration significantly reduced 3α,5α-THP immunoreactivity by 25 ± 5% in the nucleus accumbens "shore" and 21 ± 3% in the central nucleus of the amygdala. No changes were observed in the ventral tegmental area, dorsomedial striatum, granule cell layer of the DG, or the lateral and basolateral amygdala. CONCLUSIONS: The results suggest acute EtOH (2 g/kg) produces divergent, brain region specific, effects on cellular 3α,5α-THP levels. Regional differences in the effects of EtOH suggest there may be regional brain synthesis of 3α,5α-THP independent of the adrenal glands and novel mechanisms that reduce cellular 3α,5α-THP. Regional differences in EtOH-induced changes in 3α,5α-THP levels likely contribute to EtOH effects on neuronal function in brain.
BACKGROUND: The 5α-reduced pregnane neuroactive steroid (3α,5α)-3-hydroxypregnan-20-one (3α,5α-THP or allopregnanolone) is a potent positive modulator of GABAA receptors capable of modulating neuronal activity. In rats, systemic ethanol (EtOH) administration increases cerebral cortical and hippocampal levels of 3α,5α-THP, but the effects of EtOH on 3α,5α-THP levels in other brain regions are unknown. There is a large body of evidence suggesting that 3α,5α-THP enhances EtOH sensitivity, contributes to some behavioral effects of EtOH, and modulates EtOH reinforcement and motivation to drink. In this study, we used immunohistochemistry (IHC) to determine EtOH-induced changes in cellular 3α,5α-THP expression in brain regions associated with EtOH actions and responses. METHODS: Male Wistar rats were administered EtOH (2 g/kg) or saline intraperitoneally and after 60 minutes transcardially perfused. IHC was performed on free-floating sections (3 to 4 sections/animal/brain region) using an affinity purified anti-3α,5α-THP primary antibody, and immunoreactivity was visualized with 3,3'-diaminobenzidine. RESULTS:EtOH significantly increased 3α,5α-THP immunoreactivity by 24 ± 6% in the medial prefrontal cortex, 32 ± 12% in the hippocampal Cornu Ammonis area 1 (CA1) pyramidal cell layer, 52 ± 5% in the polymorph cell layer of the dentate gyrus (DG), 44 ± 15% in the bed nucleus of the stria terminalis, and 36 ± 6% in the paraventricular nucleus of the hypothalamus. In contrast, EtOH administration significantly reduced 3α,5α-THP immunoreactivity by 25 ± 5% in the nucleus accumbens "shore" and 21 ± 3% in the central nucleus of the amygdala. No changes were observed in the ventral tegmental area, dorsomedial striatum, granule cell layer of the DG, or the lateral and basolateral amygdala. CONCLUSIONS: The results suggest acute EtOH (2 g/kg) produces divergent, brain region specific, effects on cellular 3α,5α-THP levels. Regional differences in the effects of EtOH suggest there may be regional brain synthesis of 3α,5α-THP independent of the adrenal glands and novel mechanisms that reduce cellular 3α,5α-THP. Regional differences in EtOH-induced changes in 3α,5α-THP levels likely contribute to EtOH effects on neuronal function in brain.
Authors: Enrico Sanna; Giuseppe Talani; Fabio Busonero; Maria Giuseppina Pisu; Robert H Purdy; Mariangela Serra; Giovanni Biggio Journal: J Neurosci Date: 2004-07-21 Impact factor: 6.167
Authors: Laura E O'Dell; Ahmed A Alomary; Monique Vallée; George F Koob; Robert L Fitzgerald; Robert H Purdy Journal: Eur J Pharmacol Date: 2004-01-26 Impact factor: 4.432
Authors: Matthew C Beattie; Antoniette M Maldonado-Devincci; Patrizia Porcu; Todd K O'Buckley; James B Daunais; Kathleen A Grant; A Leslie Morrow Journal: Addict Biol Date: 2015-12-02 Impact factor: 4.280
Authors: Jason B Cook; David F Werner; Antoniette M Maldonado-Devincci; Maggie N Leonard; Kristen R Fisher; Todd K O'Buckley; Patrizia Porcu; Thomas J McCown; Joyce Besheer; Clyde W Hodge; A Leslie Morrow Journal: J Neurosci Date: 2014-04-23 Impact factor: 6.167
Authors: Jason B Cook; Stephanie M Nelli; Mackenzie R Neighbors; Danielle H Morrow; Todd K O'Buckley; Antoniette M Maldonado-Devincci; A Leslie Morrow Journal: Neuropsychopharmacology Date: 2014-02-25 Impact factor: 7.853
Authors: Ahmet Sait Hasirci; Antoniette M Maldonado-Devincci; Matthew C Beattie; Todd K O'Buckley; A Leslie Morrow Journal: Alcohol Clin Exp Res Date: 2017-01-09 Impact factor: 3.455
Authors: Patrizia Porcu; Todd K O'Buckley; Marcelo F Lopez; Howard C Becker; Michael F Miles; Robert W Williams; A Leslie Morrow Journal: Alcohol Date: 2016-11-10 Impact factor: 2.405
Authors: A Leslie Morrow; C J Malanga; Eric W Fish; Buddy J Whitman; Jeff F DiBerto; J Elliott Robinson Journal: Psychopharmacology (Berl) Date: 2014-05-09 Impact factor: 4.530
Authors: Matthew C Beattie; Christopher S Reguyal; Patrizia Porcu; James B Daunais; Kathleen A Grant; A Leslie Morrow Journal: Alcohol Clin Exp Res Date: 2017-12-05 Impact factor: 3.455